FEV1 stands for forced expiratory volume in one second. It measures how much air you can forcefully blow out of your lungs in the first second of a full exhalation. This single number is one of the most important measurements in lung health, used to diagnose conditions like asthma and COPD, track how well treatments are working, and gauge overall lung function over time.
How FEV1 Is Measured
FEV1 is measured during a test called spirometry. You sit down, a clip is placed on your nose to keep your nostrils closed, and you breathe into a tube connected to a machine called a spirometer. The test itself is straightforward: you take the deepest breath you can, seal your lips tightly around the tube, then blast the air out as hard and fast as possible for several seconds. Your lips need to form a complete seal so no air escapes around the edges.
You’ll repeat the test at least three times. This repetition isn’t busywork. The technician needs consistent results to confirm the readings are accurate. If your efforts vary too much between attempts, you may be asked to try again.
If your doctor wants to see how your airways respond to medication, you may do the test twice in one visit: once before using an inhaler and once after. For this reason, you’re typically asked to stop using inhalers before the appointment. Short-acting rescue inhalers like albuterol need to be withheld for 6 hours, short-acting anticholinergics for 12 hours, long-acting inhalers for 24 hours, and ultra-long-acting inhalers for 36 hours.
What Your FEV1 Number Means
Your FEV1 result is reported two ways: as an absolute volume in liters, and as a percentage of a “predicted” value. The predicted value represents what a healthy person of your same age, height, sex, and race would be expected to blow out. If your predicted FEV1 is 3.0 liters and you blow 2.4 liters, your FEV1 is 80% of predicted.
An FEV1 at or above 80% of predicted is generally considered normal. Below that, it signals some degree of airflow limitation. The further below 80% you fall, the more significant the impairment.
The percent-predicted approach has its limitations. Because the predicted value changes depending on which reference equation a lab uses, two labs could give you different severity grades for the exact same lung function. A 75-year-old man and a 40-year-old man with the same height and the same FEV1 of 1.5 liters could be classified as moderate and severe, respectively, simply because the younger man’s predicted value is higher. Predicted values are also lower for women and Black individuals, which can create inconsistencies when FEV1 is used for disability evaluations or workers’ compensation. Some researchers have argued that using absolute FEV1 values would be simpler and equally effective at predicting real-world outcomes like exercise capacity and quality of life.
Reference Equations Are Evolving
Since 2012, the Global Lung Function Initiative (GLI) reference equations have been the recommended standard worldwide. These originally used race-specific calculations for White, Black, Northeast Asian, and Southeast Asian populations. More recently, “race-neutral” global equations have been developed as an alternative. Transitioning between these two systems changes the interpretation of roughly 1 in every 13 spirometry tests, so which equation your lab uses can matter.
FEV1 and the FEV1/FVC Ratio
FEV1 alone tells you how much air comes out in one second, but it becomes far more useful when compared to your total forced vital capacity (FVC), which is the full amount of air you can exhale. This ratio, written as FEV1/FVC, is the key number doctors use to distinguish between two broad categories of lung disease.
In healthy adults, the FEV1/FVC ratio is typically around 75% to 80%, meaning you push out about three-quarters of your total air in the first second. When the ratio drops below the lower limit of normal (defined by the American Thoracic Society and European Respiratory Society as below the 5th percentile of a healthy population), it points to obstructive lung disease. In obstructive conditions like asthma and COPD, the airways are narrowed or blocked, so air comes out more slowly even though total lung capacity may be normal.
When both FEV1 and FVC are reduced but their ratio stays normal or even increases, that pattern suggests restrictive lung disease. Restrictive conditions, like pulmonary fibrosis or chest wall deformities, limit how much the lungs can expand in the first place.
How FEV1 Classifies COPD Severity
For people with COPD, FEV1 is the backbone of severity staging. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) system divides COPD into four stages based on your post-bronchodilator FEV1 as a percentage of predicted:
- GOLD Stage I (Mild): FEV1 is 80% of predicted or higher
- GOLD Stage II (Moderate): FEV1 is 50% to 79% of predicted
- GOLD Stage III (Severe): FEV1 is 30% to 49% of predicted
- GOLD Stage IV (Very Severe): FEV1 is below 30% of predicted
These stages help guide treatment decisions. Someone in Stage I may need only a rescue inhaler and lifestyle adjustments, while someone in Stage IV typically requires more intensive, combination therapies and close monitoring.
FEV1 in Asthma Diagnosis
In asthma, FEV1 plays a slightly different role. Because asthma involves reversible airway narrowing, doctors look for a specific improvement in FEV1 after you use a bronchodilator during the test. An increase of at least 12% from your starting value, along with an absolute increase of at least 200 milliliters, is considered significant reversibility. This pattern, where airways open up substantially in response to medication, is a hallmark of asthma and helps distinguish it from COPD, where reversibility is typically more limited.
The FEV1/FVC ratio also factors into asthma severity classification. The Global Initiative for Asthma uses a ratio below 75% to 80% as one marker of airflow limitation. In practice, though, many people with asthma have completely normal spirometry between flare-ups, which is why doctors sometimes use additional challenge tests to provoke airway narrowing when baseline results look fine.
What Causes a Low FEV1
A reduced FEV1 reflects something physically limiting how fast air can leave your lungs. The most common culprits are airway spasm (where the muscles around the airways tighten), inflammation that swells and thickens the airway walls, loss of the natural elastic recoil that helps the lungs snap back during exhalation, and excess mucus or secretions clogging the airways. These mechanisms overlap in conditions like COPD and asthma but also show up in bronchiectasis, cystic fibrosis, and other lung diseases.
FEV1 can also decline naturally with age. After peaking in your mid-20s, lung function gradually decreases over time, even in healthy nonsmokers. This is why the predicted value adjusts for age. A 70-year-old with an FEV1 of 2.5 liters may be perfectly normal, while that same number in a 30-year-old could signal a problem.
Tracking FEV1 Over Time
A single FEV1 reading gives a snapshot, but tracking it over months and years reveals the trajectory of your lung health. In COPD, a steeper-than-expected decline in FEV1 may signal that the disease is progressing faster than anticipated or that current treatment isn’t adequate. In asthma, fluctuations in FEV1 between visits can reveal how well controlled the condition is, even when you feel fine day to day.
For this reason, people with chronic lung conditions typically undergo spirometry at regular intervals. Comparing your current FEV1 to your own previous readings is often more meaningful than comparing to a population-based predicted value, because it eliminates the variability introduced by different reference equations and demographic assumptions.